GlassScriptPhysician profile
Alexandra Allen
NPI 1255831384
$1,950.19
in general payments reported to CMS, 2019-2025
12 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $600 · 2023: $680 · 2024: $284 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785 · Travel and Lodging: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.17 |
| Travel and Lodging | $565.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,011.76 | 2022-2023 | Da Vinci Surgical System |
| Novartis Pharmaceuticals Corporation | $186.74 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $153.32 | 2024-2025 | Dupixent |
| Averitas Pharma INC. | $111.96 | 2023-2024 | Qutenza |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Pfizer INC. | $81.55 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $79.55 | 2024 | |
| Abbvie INC. | $69.08 | 2023 | |
| Collegium Pharmaceutical, INC. | $54.41 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.85 | 2022 | |
| Grt US Holding, INC. | $45.00 | 2022 | |
| Janssen Biotech, INC. | $18.92 | 2024 | Simponi Aria, Tremfya, Stelara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.